Kaleidoscope

Kaleidoscope

NYC
Building Kaleidoscope.bio to make science more collaborative, reproducible, and scalable.
Jul
16

Every day counts in biotech R&D

When I was seven years old, my mom was diagnosed with leukemia. We were a freshly immigrated family, still figuring
3 min read
Jul
01

What your biotech engineering team should never build

As a biotech company, every resource - minute, dollar, and FTE focus - counts in your race to reach market.
5 min read
Jun
09

Driving commercial success in biopharma: in conversation with Paul Sekhri

What does it take to effectively commercialize a drug? How can biotech leaders successfully navigate this long, winding, and expensive
4 min read
Jun
04

Biotech markets are down. So what?

The most misguided assumption in biotech investing right now is that tough markets hurt everyone equally. We've been
4 min read
May
22

How CROs reshaped biotech and why it matters today

Biotech today runs on an interconnected web of partners: CROs, CDMOs, academic labs, and startup biotechs all working in tandem.
5 min read
May
07

What biotechs can learn about outsourcing work

CROs, CDMOs, and other external parties are crucial pieces of the Life Science commercialization puzzle. But while biotech has embraced
6 min read
Apr
17

The Accidental Operator

Last month, we wrote about why operational roles matter more in biotech than people think. The response was fantastic – it
5 min read
Mar
28

Beyond Algorithms: Software Infrastructure for AI/ML Biotechs

Many of today's biotechs look nothing like yesterday’s. Companies can now run thousands of experiments in parallel,
7 min read
Mar
06

The case for scientific PMs

At Kaleidoscope, we've collaborated with many types of project and program managers. Over time, we've found
3 min read
Feb
26

Why Ops roles in biotech matter more than you think

Operational roles, like project or program management, can have an outsized impact on a biotech's likelihood of success.
6 min read